161 related articles for article (PubMed ID: 34130325)
1. [Diagnosis and therapy of erysipelas: A position paper of the Society Initiative Chronische Wunde (ICW) e. V.].
Kröger K; Schwarzkopf A; Eder S; Protz K; Münter C; Dissemond J
Dtsch Med Wochenschr; 2021 Jun; 146(12):822-830. PubMed ID: 34130325
[TBL] [Abstract][Full Text] [Related]
2. [Erysipelas].
Caetano M; Amorin I
Acta Med Port; 2005; 18(5):385-93. PubMed ID: 16611543
[TBL] [Abstract][Full Text] [Related]
3. [Bacterial skin and soft tissue infections].
Hanses F
Z Rheumatol; 2017 Nov; 76(9):745-751. PubMed ID: 28879609
[TBL] [Abstract][Full Text] [Related]
4. [Non-Necrotizing Acute Dermo-Hypodermal Infections: Erysipela and Infectious Cellulitis].
Rodrigues MA; Caetano M; Amorim I; Selores M
Acta Med Port; 2021 Mar; 34(3):217-228. PubMed ID: 33971117
[TBL] [Abstract][Full Text] [Related]
5. Erysipelas: recognition and management.
Bonnetblanc JM; Bédane C
Am J Clin Dermatol; 2003; 4(3):157-63. PubMed ID: 12627991
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of laboratory parameters for the discrimination between erysipelas and limited cellulitis.
Drerup C; Eveslage M; Sunderkoetter C; Ehrchen J
J Dtsch Dermatol Ges; 2020 Dec; 18(12):1417-1424. PubMed ID: 33035396
[TBL] [Abstract][Full Text] [Related]
7. [Compression is important in erysipelas treatment].
Villefrance M; Høgh A; Kristensen LH
Ugeskr Laeger; 2017 Oct; 179(41):. PubMed ID: 28992840
[TBL] [Abstract][Full Text] [Related]
8. [Erysipelas and lymphedema].
Herpertz U
Fortschr Med; 1998 Apr; 116(12):36-40. PubMed ID: 9622973
[TBL] [Abstract][Full Text] [Related]
9. [Recurrent erysipelas].
Dangoisse C; Ledoux M
Rev Med Brux; 1991 Sep; 12(7):253-6. PubMed ID: 1925175
[TBL] [Abstract][Full Text] [Related]
10. Erysipelas as a sign of subclinical primary lymphoedema: a prospective quantitative scintigraphic study of 40 patients with unilateral erysipelas of the leg.
Damstra RJ; van Steensel MA; Boomsma JH; Nelemans P; Veraart JC
Br J Dermatol; 2008 Jun; 158(6):1210-5. PubMed ID: 18363756
[TBL] [Abstract][Full Text] [Related]
11. Frequent bacterial skin and soft tissue infections: diagnostic signs and treatment.
Sunderkötter C; Becker K
J Dtsch Dermatol Ges; 2015 Jun; 13(6):501-24; quiz 525-6. PubMed ID: 26018361
[TBL] [Abstract][Full Text] [Related]
12. [Necrotizing erysipelas bordering on necrotizing fasciitis].
Schulte KW; Roller E; Bacmann D; Stege H
Hautarzt; 2003 Oct; 54(10):989-90. PubMed ID: 14513252
[No Abstract] [Full Text] [Related]
13. Uncommon manifestations of erysipelas.
Török L
Clin Dermatol; 2005; 23(5):515-8. PubMed ID: 16179186
[TBL] [Abstract][Full Text] [Related]
14. [Cellulitis: clinical manifestations and management].
Blum CL; Menzinger S; Genné D
Rev Med Suisse; 2013 Oct; 9(401):1812-5. PubMed ID: 24191414
[TBL] [Abstract][Full Text] [Related]
15. Erysipelas: a common potentially dangerous infection.
Celestin R; Brown J; Kihiczak G; Schwartz RA
Acta Dermatovenerol Alp Pannonica Adriat; 2007 Sep; 16(3):123-7. PubMed ID: 17994173
[TBL] [Abstract][Full Text] [Related]
16. [Primary and secondary prevention for erysipelas].
Becq-Giraudon B
Ann Dermatol Venereol; 2001 Mar; 128(3 Pt 2):368-75. PubMed ID: 11319367
[TBL] [Abstract][Full Text] [Related]
17. [Position paper of the Initiative Chronische Wunde (ICW) e. V. on the nomenclature of debridement in chronic wounds].
Dissemond J; Bültemann A; Gerber V; Motzkus M; Münter KC; Erfurt-Berge C
Hautarzt; 2022 May; 73(5):369-375. PubMed ID: 35072741
[TBL] [Abstract][Full Text] [Related]
18. [Erysipelas without fever or biologic inflammation during tocilizumab therapy].
Yéléhé-Okouma M; Henry J; Petitpain N; Schmutz JL; Gillet P
Ann Dermatol Venereol; 2017; 144(6-7):434-437. PubMed ID: 28396064
[TBL] [Abstract][Full Text] [Related]
19. [Skin and soft tissue infections].
Piso RJ; Bassetti S
Praxis (Bern 1994); 2012 Mar; 101(6):399-405. PubMed ID: 22419138
[TBL] [Abstract][Full Text] [Related]
20. [Is compression therapy contraindicated for lower leg erysipelas? : Results of a retrospective analysis].
Eder S; Stücker M; Läuchli S; Dissemond J
Hautarzt; 2021 Jan; 72(1):34-41. PubMed ID: 32930854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
